VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Amgen Inc. vs KONE Oyj
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
KONE Oyj
KNEBV · Nasdaq Helsinki
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 63 / 100 for KONE Oyj).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); KONE Oyj has 3 segments (40.6% in New Building Solutions).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Weak.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; KONE Oyj has 8 across 4.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
KONE Oyj
New Building Solutions
Elevator, escalator and automatic building door new equipment (new installations)
Global
Property developers and general contractors
OEM + project installation
40.6%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
KONE Oyj strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
KONE Oyj segments
Full profile >New Building Solutions
Oligopoly
Service (maintenance & repairs)
Competitive
Modernization
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.